Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: a Phase I, open-label, dose-escalation clinical study. - Burge DJ; Bookbinder SA; Kivitz AJ; Fleischmann RM; Shu C; Bannink J (Clinical therapeutics, 2008)